Tilray Brands Inc
2HQ
Company Profile
Business description
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
Contact
265 Talbot Street West
LeamingtonONN8H 5L4
CANT: +1 844 845-7291
E: mgalloro@aloefinancial.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 May 2025
Employees
2,650
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,561.70 | 142.70 | -1.85% |
| CAC 40 | 6,890.92 | 209.50 | -2.95% |
| DAX 40 | 19,740.47 | 539.79 | -2.66% |
| Dow JONES (US) | 37,634.57 | 11.02 | -0.03% |
| FTSE 100 | 7,688.55 | 221.98 | -2.81% |
| HKSE | 20,264.49 | 136.81 | 0.68% |
| NASDAQ | 15,471.87 | 203.96 | 1.34% |
| Nikkei 225 | 31,714.03 | 1,298.55 | -3.93% |
| NZX 50 Index | 11,806.55 | 84.89 | -0.71% |
| S&P 500 | 5,000.28 | 17.51 | 0.35% |
| S&P/ASX 200 | 7,375.00 | 135.00 | -1.80% |
| SSE Composite Index | 3,186.81 | 41.26 | 1.31% |